UTAH MEDICAL PRODUCTS, INC. Cash and Restricted Cash
UTAH MEDICAL PRODUCTS, INC. (UTMD) had Cash and Restricted Cash of $87.53 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-12
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $87.53M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $87.41M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $85.76M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $84.27M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $87.53M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $87.41M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $85.76M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $84.27M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $82.18M 10-Q · filed 2026-08-12 |
| 2025-03-31 | $83.33M 10-Q · filed 2026-05-12 |
| 2024-12-31 | $82.98M 10-Q · filed 2026-08-12 |
| 2024-09-30 | $88.45M 10-Q · filed 2025-11-14 |
| 2024-06-30 | $89.22M 10-Q · filed 2025-08-12 |
| 2024-03-31 | $93.81M 10-Q · filed 2025-05-15 |
| 2023-12-31 | $92.87M 10-K · filed 2026-03-27 |
| 2023-09-30 | $88.21M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $84.62M 10-Q · filed 2024-08-09 |
| 2023-03-31 | $80.91M 10-Q · filed 2024-05-10 |
| 2022-12-31 | $75.05M 10-K · filed 2026-03-27 |
| 2022-09-30 | $69.51M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $66.22M 10-Q · filed 2023-08-11 |
| 2022-03-31 | $65.87M 10-Q · filed 2023-05-05 |
| 2021-12-31 | $60.97M 10-K · filed 2025-03-26 |
| 2020-12-31 | $51.59M 10-K · filed 2024-03-26 |
| 2019-12-31 | $42.79M 10-K/A · filed 2023-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |